Chemed EBITDA Margin 2010-2024 | CHE

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Chemed (CHE) over the last 10 years. The current EBITDA margin for Chemed as of June 30, 2024 is .
Chemed EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $2.29B $0.40B 17.52%
2023-12-31 $2.27B $0.40B 17.75%
2023-09-30 $2.23B $0.37B 16.67%
2023-06-30 $2.19B $0.37B 16.69%
2023-03-31 $2.16B $0.39B 17.88%
2022-12-31 $2.14B $0.40B 18.88%
2022-09-30 $2.13B $0.42B 19.68%
2022-06-30 $2.14B $0.43B 20.07%
2022-03-31 $2.14B $0.41B 19.18%
2021-12-31 $2.14B $0.40B 18.79%
2021-09-30 $2.13B $0.45B 21.02%
2021-06-30 $2.12B $0.43B 20.28%
2021-03-31 $2.09B $0.45B 21.48%
2020-12-31 $2.08B $0.45B 21.50%
2020-09-30 $2.07B $0.38B 18.42%
2020-06-30 $2.02B $0.37B 18.21%
2020-03-31 $1.99B $0.34B 16.91%
2019-12-31 $1.94B $0.30B 15.68%
2019-09-30 $1.88B $0.29B 15.47%
2019-06-30 $1.84B $0.29B 15.51%
2019-03-31 $1.81B $0.28B 15.34%
2018-12-31 $1.78B $0.28B 15.87%
2018-09-30 $1.75B $0.27B 15.46%
2018-06-30 $1.73B $0.26B 15.24%
2018-03-31 $1.70B $0.17B 9.71%
2017-12-31 $1.67B $0.15B 9.00%
2017-09-30 $1.64B $0.15B 8.90%
2017-06-30 $1.62B $0.14B 8.35%
2017-03-31 $1.59B $0.21B 13.38%
2016-12-31 $1.58B $0.22B 13.71%
2016-09-30 $1.57B $0.21B 13.55%
2016-06-30 $1.57B $0.22B 14.06%
2016-03-31 $1.56B $0.23B 14.45%
2015-12-31 $1.54B $0.22B 14.25%
2015-09-30 $1.52B $0.22B 14.44%
2015-06-30 $1.50B $0.21B 14.04%
2015-03-31 $1.47B $0.21B 14.11%
2014-12-31 $1.46B $0.21B 14.16%
2014-09-30 $1.43B $0.20B 13.82%
2014-06-30 $1.41B $0.19B 13.35%
2014-03-31 $1.41B $0.17B 12.31%
2013-12-31 $1.41B $0.18B 12.45%
2013-09-30 $1.43B $0.18B 12.69%
2013-06-30 $1.45B $0.19B 13.06%
2013-03-31 $1.44B $0.20B 13.99%
2012-12-31 $1.43B $0.20B 13.71%
2012-09-30 $1.41B $0.20B 13.89%
2012-06-30 $1.40B $0.20B 14.31%
2012-03-31 $1.38B $0.20B 14.23%
2011-12-31 $1.36B $0.19B 14.17%
2011-09-30 $1.34B $0.18B 13.72%
2011-06-30 $1.32B $0.18B 13.56%
2011-03-31 $1.30B $0.18B 13.59%
2010-12-31 $1.28B $0.18B 14.06%
2010-09-30 $1.25B $0.17B 13.79%
2010-06-30 $1.22B $0.17B 13.64%
2010-03-31 $1.20B $0.16B 13.37%
2009-12-31 $1.19B $0.16B 13.53%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.190B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.391B 11.73
Quest Diagnostics (DGX) United States $16.058B 16.47
DaVita (DVA) United States $12.497B 15.52
Encompass Health (EHC) United States $9.126B 23.36
Elanco Animal Health (ELAN) United States $6.335B 16.44
Option Care Health (OPCH) United States $5.388B 20.40
RadNet (RDNT) United States $4.578B 95.34
Amedisys (AMED) United States $3.194B 22.89
Astrana Health (ASTH) United States $2.939B 39.76
Addus HomeCare (ADUS) United States $2.192B 28.36
LifeStance Health (LFST) United States $2.118B 0.00
U.S Physical Therapy (USPH) United States $1.462B 39.11
Pennant (PNTG) United States $0.878B 46.37
Aveanna Healthcare Holdings (AVAH) United States $0.818B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00